|
Volumn 58, Issue 3, 2003, Pages 215-219
|
Postmarketing Evaluation of Drugs: Actual Efficacy, Population Exposed and Impact on Public Health;Evaluation des Médicaments Après la Commercialisation: Efficacité Réelle, Population Exposée et Impact sur la Santé Publique
|
Author keywords
Commercialisation; Drugs; Efficacy; Evaluation; Population exposed; Public health
|
Indexed keywords
DRUG;
ADVERSE DRUG REACTION;
CLINICAL TRIAL;
CONFERENCE PAPER;
DATA BASE;
DRUG EFFICACY;
DRUG MARKETING;
DRUG SAFETY;
DRUG SCREENING;
DRUG SURVEILLANCE PROGRAM;
DRUG UTILIZATION;
HEALTH CARE SYSTEM;
HUMAN;
META ANALYSIS;
METHODOLOGY;
MORBIDITY;
MORTALITY;
PHARMACOEPIDEMIOLOGY;
POSTMARKETING SURVEILLANCE;
PRIORITY JOURNAL;
PROGNOSIS;
|
EID: 0344033854
PISSN: 00405957
EISSN: None
Source Type: Journal
DOI: 10.2515/therapie:2003033 Document Type: Conference Paper |
Times cited : (1)
|
References (7)
|